Literature DB >> 3744548

Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptability to various vehicles and pyrogenicity.

M Tsujimoto, S Kotani, F Kinoshita, S Kanoh, T Shiba, S Kusumoto.   

Abstract

Thirteen 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamines (6-O-acyl-MDPs), including four inactive D-isoasparagine and L-isoglutamine analogs, were tested for their pyrogenicity and immunopotentiating activity to stimulate primary humoral and cellular immune responses in guinea pigs to a model protein antigen, ovalbumin, when administered in various vehicles. Among them, derivatives whose muramic acid residue was substituted by alpha-branched (and beta-hydroxylated) higher fatty acids at the carbon-6 position, especially 6-O-(2-tetradecylhexadecanoyl)-MDP (B3O-MDP) and, to a lesser extent, 6-O-(3-hydroxy-2-docosylhexacosanoyl)-MDP (BH48-MDP) and its L-serine analog [BH48-MDP(L-Ser)], were found to exert strong adjuvant activity in both the induction of delayed-type hypersensitivity and the stimulation of circulating precipitating antibody levels when combined with nonirritating vehicles (liposomes, squalene-in-water emulsion, and phosphate-buffered saline). These vehicles did not efficiently support the adjuvant activity of MDP, the parent molecule of the above lipophilic derivatives. Pyrogenicity tests showed that introduction of alpha-branched higher fatty acid groups but not of straight, long-chain fatty acids at the 6-position of the muramic acid residue resulted in marked decrease of the pyrogenicity inherent to MDP via intravenous administration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3744548      PMCID: PMC260819          DOI: 10.1128/iai.53.3.511-516.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Modulation of the immune response by a synthetic adjuvant and analogs.

Authors:  L Chedid; F Audibert; P Lefrancier; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

2.  Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components.

Authors:  F Audibert; L Chédid; P Lefrancier; J Choay
Journal:  Cell Immunol       Date:  1976-02       Impact factor: 4.868

Review 3.  Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.

Authors:  L Chedid; F Audibert; A G Johnson
Journal:  Prog Allergy       Date:  1978

4.  Effects of chemical modifications of the glutamic acid residue in N-acetylmuramyl peptides on the immunoadjuvancies of the molecules.

Authors:  S Kotani; F Kinoshita; Y Watanabe; I Morisaki; T Shimono; K Kato; T Shiba; S Kusumoto; K Ikenaka; Y Tarumi
Journal:  Biken J       Date:  1977-12

5.  Enhancement of dengue virus infection in cultured mouse macrophages by lipophilic derivatives of muramyl peptides.

Authors:  H Hotta; L F Sanchez; H Takada; M Homma; S Kotani
Journal:  Microbiol Immunol       Date:  1985       Impact factor: 1.955

6.  The adjuvant activity of a non-toxic, water-soluble glycopeptide present in large quantities in the culture filtrate of Mycobacterium tuberculosis strain DT.

Authors:  D E Stewart-Tull; T Shimono; S Kotani; M Kato; Y Ogawa; Y Yamamura; T Koga; C M Pearson
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

7.  The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules.

Authors:  S Kotani; Y Watanabe; F Kinoshita; I Morisaki; K Kato
Journal:  Biken J       Date:  1977-06

8.  Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oil.

Authors:  E Yarkoni; H J Rapp
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

9.  Immunoadjuvant activities of cell walls and their water-soluble fractions prepared from various gram-positive bacteria.

Authors:  S Kotani; T Narita; D E Stewart-Tull; T Shimono; Y Watanabe
Journal:  Biken J       Date:  1975-06

10.  Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.

Authors:  S Kotani; F Kinoshita; I Morisaki; T Shimono; T Okunaga; H Takada; M Tsujimoto; Y Watanabe; K Kato; T Shiba; S Kusumoto; S Okada
Journal:  Biken J       Date:  1977-12
View more
  7 in total

1.  Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.

Authors:  G S Hui; L Q Tam; S P Chang; S E Case; C Hashiro; W A Siddiqui; T Shiba; S Kusumoto; S Kotani
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

2.  Structural requirements of muramylpeptides for induction of necrosis at sites primed with Mycobacterium tuberculosis in guinea pigs.

Authors:  S Nagao; H Takada; K Yagawa; H Kutsukake; T Shiba; S Kusumoto; S Kawata; A Hasegawa; M Kiso; I Azuma
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

3.  Enhancement of immunoglobulin G responses in mice against hepatitis B virus surface antigen, influenza virus hemagglutinin vaccine, and tetanus toxoid by 6-O-acylated muramyl dipeptides.

Authors:  T Furuya; Y Kumazawa; H Takimoto; T Nagumo; M Watanabe; C Aizawa; M Kiso; A Hasegawa; K Nomoto
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

Review 4.  Molecular adjuvants and immunomodulators: new approaches to immunization.

Authors:  A G Johnson
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

5.  Differences in proinflammatory activity of several immunomodulatory derivatives of muramyl dipeptide (MDP) with special reference to the mechanism of the MDP effects.

Authors:  Z Zídek
Journal:  Agents Actions       Date:  1992-05

Review 6.  Translation of peptidoglycan metabolites into immunotherapeutics.

Authors:  Matthew E Griffin; Charles W Hespen; Yen-Chih Wang; Howard C Hang
Journal:  Clin Transl Immunology       Date:  2019-11-29

7.  A synthetic adjuvant effective in inducing antitumor immunity.

Authors:  T Kataoka; T Tokunaga
Journal:  Jpn J Cancer Res       Date:  1988-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.